ATYR PHARMA INC (ATYR) Stock Balance Sheet
NASDAQ:ATYR - Nasdaq - US0021202025 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 10.36M | 11.05M | 22.54M | 9.98M | 2.34M | |||
| Marketable Securities | 65.99M | 61.07M | 75.62M | 56.16M | 105.58M | |||
| Receivables | 988.00K | 1.74M | 2.44M | 11.78M | 435.00K | |||
| Other Current Assets | 5.93M | 8.09M | 2.39M | 2.95M | 5.22M | |||
| Total Current Assets | 83.27M | 81.95M | 102.99M | 80.87M | 113.57M | |||
| Non-Current Assets | ||||||||
| PPE Net | 11.48M | 11.86M | 14.05M | 11.56M | 1.81M | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 2.50M | 3.02M | 3.62M | 3.36M | 158.00K | |||
| Total Non-Current Assets | 13.97M | 14.88M | 17.66M | 14.91M | 1.97M | |||
| TOTAL ASSETS | 97.25M | 96.83M | 120.65M | 95.79M | 115.54M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 550.00K | 541.00K | 497.00K | 264.00K | N/A | |||
| Accrued Expenses | 8.60M | 10.10M | 12.39M | 10.49M | 4.98M | |||
| Accounts Payable | 1.53M | 4.32M | 3.53M | 3.11M | 1.03M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 10.68M | 14.97M | 16.42M | 13.86M | 6.01M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 747.00K | 887.00K | 1.43M | 1.01M | 0.00 | |||
| Other Non-Current Liabilities | 10.95M | 11.14M | 12.34M | 9.63M | 398.00K | |||
| Total Non-Current Liabilities | 11.51M | 11.84M | 13.58M | 10.46M | 223.00K | |||
| TOTAL LIABILITIES | 22.20M | 26.81M | 30.00M | 24.32M | 6.24M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -546.93M | -532.05M | -468.02M | -417.63M | -372.30M | |||
| Additional Paid In Capital | 621.95M | 602.02M | 558.69M | 489.50M | 481.83M | |||
| Minority Interest | -188.00K | -187.00K | -188.00K | -180.00K | -175.00K | |||
| Common Shares | 89.00K | 84.00K | 63.00K | 29.00K | 28.00K | |||
| Other Shareholders' Equity | -66.00K | -40.00K | -74.00K | -433.00K | -263.00K | |||
| Shares Outstanding | 89.00M | 84.04M | 63.29M | 29.50M | 27.79M | |||
| Tangible Book Value per Share | 0.84 | 0.83 | 1.43 | 2.42 | 3.93 | |||
| Total Shareholders' Equity | 75.05M | 70.02M | 90.66M | 71.46M | 109.30M | |||
| TOTAL LIABILITIES AND EQUITY | 97.25M | 96.83M | 120.65M | 95.79M | 115.54M | |||
| Statistics | ||||||||
| Debt/Equity | 0.01 | 0.01 | 0.02 | 0.01 | N/A | |||
| Current Ratio | 7.79 | 5.48 | 6.27 | 5.83 | 18.89 | |||
| Return On Assets (ROA) | -65.21% | -66.12% | -41.76% | -47.33% | -29.23% | |||
| Return On Equity (ROE) | -84.49% | -91.44% | -55.58% | -63.44% | -30.89% | |||
All data in USD , ROIC based on taxRate of 0.21